Physician profile
C Mike Meek
NPI 1174786776
$508,812.18
in general payments reported to CMS, 2019-2025
7 companies · $68K in 2025
The $68K reported for 2025 was more than what 99% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52K · 2020: $16.13 · 2021: $31K · 2022: $205K · 2023: $59K · 2024: $93K · 2025: $68K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $138K · Consulting Fee: $78K · Food and Beverage: $4,356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $137,959.12 |
| Consulting Fee | $77,999.39 |
| Food and Beverage | $4,355.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $347,390.47 | 2019-2023 | Education, Nobelactive |
| Envista Holdings Corporation | $160,790.06 | 2024-2025 | Education |
| Ultradent Products INC | $338.97 | 2022 | |
| 3m Company | $112.87 | 2021-2022 | |
| Ormco Corporation | $92.39 | 2023 | Spark |
| Straumann USA LLC | $54.23 | 2024 | |
| Solventum Corporation | $33.19 | 2025 | 3m Scotchbond |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw C Mike Meek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.